Share-based Payment Arrangement, Expense of aTYR PHARMA INC from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
aTYR PHARMA INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • aTYR PHARMA INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,307,000, a 74% increase year-over-year.
  • aTYR PHARMA INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $4,560,000, a 58% increase year-over-year.
  • aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2024 was $2,989,000, a 15% increase from 2023.
  • aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2023 was $2,600,000, a 21% increase from 2022.
  • aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2022 was $2,154,000, a 33% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

aTYR PHARMA INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,560,000 $1,307,000 +$555,000 +74% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $4,005,000 $1,305,000 +$578,000 +80% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $3,427,000 $1,178,000 +$438,000 +59% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $2,989,000 $770,000 +$111,000 +17% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $2,878,000 $752,000 +$88,000 +13% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $2,790,000 $727,000 +$69,000 +10% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $2,721,000 $740,000 +$121,000 +20% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $2,600,000 $659,000 +$54,000 +8.9% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $2,546,000 $664,000 +$49,000 +8% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $2,497,000 $658,000 +$141,000 +27% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $2,356,000 $619,000 +$202,000 +48% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $2,154,000 $605,000 +$191,000 +46% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
Q3 2022 $1,963,000 $615,000 +$173,000 +39% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,790,000 $517,000 +$119,000 +30% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $1,671,000 $417,000 +$57,000 +16% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $1,614,000 $414,000 +$74,000 +22% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $1,540,000 $442,000 +$118,000 +36% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $1,422,000 $398,000 +$20,000 +5.3% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $1,402,000 $360,000 -$63,000 -15% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $1,465,000 $340,000 -$85,000 -20% 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2023 2022 FY
Q3 2020 $1,550,000 $324,000 +$46,000 +17% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $1,504,000 $378,000 -$131,000 -26% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $1,635,000 $423,000 -$148,000 -26% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $1,783,000 $425,000 -$177,000 -29% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2022 2021 FY
Q3 2019 $1,960,000 $278,000 -$412,000 -60% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $2,372,000 $509,000 -$702,000 -58% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $3,074,000 $571,000 -$357,000 -38% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q4 2018 $3,431,000 $602,000 -$2,533,000 -81% 01 Oct 2018 31 Dec 2018 10-K 24 Mar 2021 2020 FY
Q3 2018 $5,964,000 $690,000 -$499,000 -42% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $6,463,000 $1,211,000 +$28,000 +2.4% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $6,435,000 $928,000 -$349,000 -27% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $6,784,000 $3,135,000 +$1,983,000 +172% 01 Oct 2017 31 Dec 2017 10-K 26 Mar 2020 2019 FY
Q3 2017 $4,801,000 $1,189,000 -$35,000 -2.9% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $4,836,000 $1,183,000 -$190,000 -14% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $5,026,000 $1,277,000 -$3,000 -0.23% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $5,029,000 $1,152,000 -$1,235,000 -52% 01 Oct 2016 31 Dec 2016 10-K 26 Mar 2019 2018 FY
Q3 2016 $6,264,000 $1,224,000 +$174,000 +17% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $6,090,000 $1,373,000 +$557,000 +68% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $5,533,000 $1,280,000 +$677,000 +112% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $4,856,000 $2,387,000 +$1,381,000 +137% 01 Oct 2015 31 Dec 2015 10-K 20 Mar 2018 2017 FY
Q3 2015 $3,475,000 $1,050,000 +$576,000 +122% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $2,899,000 $816,000 +$651,000 +395% 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2016 2016 Q2
Q1 2015 $2,248,000 $603,000 +$457,000 +313% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q4 2014 $1,791,000 $1,006,000 01 Oct 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
Q3 2014 $474,000 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2015 2015 Q3
Q2 2014 $165,000 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 $146,000 01 Jan 2014 31 Mar 2014 10-Q 18 Jun 2015 2015 Q1

aTYR PHARMA INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,989,000 +$389,000 +15% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $2,600,000 +$446,000 +21% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $2,154,000 +$540,000 +33% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
2021 $1,614,000 +$149,000 +10% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2024 2023 FY
2020 $1,465,000 -$318,000 -18% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2023 2022 FY
2019 $1,783,000 -$1,648,000 -48% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2022 2021 FY
2018 $3,431,000 -$3,353,000 -49% 01 Jan 2018 31 Dec 2018 10-K 24 Mar 2021 2020 FY
2017 $6,784,000 +$1,755,000 +35% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2020 2019 FY
2016 $5,029,000 +$173,000 +3.6% 01 Jan 2016 31 Dec 2016 10-K 26 Mar 2019 2018 FY
2015 $4,856,000 +$3,065,000 +171% 01 Jan 2015 31 Dec 2015 10-K 20 Mar 2018 2017 FY
2014 $1,791,000 +$1,636,000 +1055% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017 2016 FY
2013 $155,000 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.